BIOMERIEUX (EPA:BIM) | Finanzwire

Basculer en Français

10055	Companies
205416	Keywords
135634	Articles
108895	Press releases

Home
Companies
BIOMERIEUX

REGULATED PRESS RELEASE

published on 05/28/2024 at 18:01, 1 year 9 months ago

bioMérieux receives FDA 510(k) clearance of VIDAS® TBI (GFAP, UCH-L1), an innovative test to improve the assessment of patients with mild traumatic brain injury
bioMérieux receives FDA 510(k) clearance of VIDAS TBI (GFAP, UCH-L1), a serum-based test to support the assessment of patients with mild traumatic brain injury, improving patient outcomes. The test uses biomarkers to predict absence of acute intracranial lesions

BioMérieux FDA 510(k) Clearance Biomarkers VIDAS TBI Mild Traumatic Brain Injury
BRIEF

published on 05/23/2024 at 13:07, 1 year 9 months ago

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country's First Multisectoral Collaboration to Address Antimicrobial Resistance

BioMérieux Antimicrobial Resistance Public Health Pfizer Malawi Health
REGULATED PRESS RELEASE

published on 05/23/2024 at 13:02, 1 year 9 months ago

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance
Malawi Ministry of Health, bioMérieux, and Pfizer collaborate to address antimicrobial resistance in Malawi through infection prevention, control, diagnostics, and surveillance. The initiative aims to combat AMR, a global health threat

BioMérieux Antimicrobial Resistance Collaboration Pfizer Malawi Ministry Of Health
BRIEF

published on 05/06/2024 at 17:23, 1 year 10 months ago

BioMérieux financial update: Overview of share capital and voting rights in April 2024

Share Capital Voting Rights BioMérieux Actions In Vitro Diagnostics
BRIEF

published on 04/09/2024 at 07:20, 1 year 11 months ago

BioMérieux Outlines Ambitious Five-Year Strategic Growth Plan

Corporate Social Responsibility BioMérieux In Vitro Diagnostics Sustainable Growth GO•28 Strategic Plan
REGULATED PRESS RELEASE

published on 04/09/2024 at 07:15, 1 year 11 months ago

bioMérieux presents its new 5-year strategic plan and its targets for profitable growth
bioMérieux unveils its 5-year strategic plan, GO•28, aimed at sustainable growth and responsiblity. Targets include +7% organic revenue growth and -50% GHG emissions by 2030

BioMérieux Strategic Plan Organic Growth GHG Emissions GO•28
BRIEF

published on 04/09/2024 at 07:06, 1 year 11 months ago

BioMérieux Posts Strong First-Quarter 2024 Results with Outstanding Sales Growth

BioMérieux In Vitro Diagnostics First-Quarter 2024 BIOFIRE® Panels SPOTFIRE®
REGULATED PRESS RELEASE

published on 04/09/2024 at 07:01, 1 year 11 months ago

bioMérieux – First-Quarter 2024 Business Review
bioMérieux reports strong +10% organic sales growth in the first quarter of 2024, driven by BIOFIRE® and microbiology segments. Sales reach €965 million. Company confirms 2024 guidance for sales and operating profit

BioMérieux Organic Sales Growth 2024 Guidance BIOFIRE® Microbiology
BRIEF

published on 04/05/2024 at 09:04, 1 year 11 months ago

BioMérieux announces its number of shares and voting rights for March 2024

Share Capital Voting Rights BioMérieux Actions March 2024
BRIEF

published on 04/05/2024 at 07:06, 1 year 11 months ago

BioMérieux and Mérieux NutriSciences Launch Collaborative Data-Driven Initiative for Food Safety

BioMérieux Food Safety Industry Collaboration Data-driven Initiative Consumer Safety

Accesswire

Published on 03/20/2026 at 03:10, 1 hour 14 minutes ago

Future Fuels Announces Filing of Amended and Restated Life Offering Document
Published on 03/20/2026 at 00:20, 4 hours 4 minutes ago

Prospect Ridge To Host Investor Webinar With Presentation And Audience Q&A
Published on 03/20/2026 at 00:20, 4 hours 4 minutes ago

Reeflex Solutions Inc. Announces Revocation of Management Cease Trade Order
Published on 03/19/2026 at 21:16, 7 hours 8 minutes ago

Unusual Machines, Inc. Announces Proposed Public Offering
Published on 03/19/2026 at 14:20, 14 hours 4 minutes ago

CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report

View all ACCESSWIRE

EQS Group

Published on 03/20/2026 at 03:05, 1 hour 19 minutes ago

HEROAD Unleashes a New Era of Gaming: Professional-Grade Gear Meets Unbeatable Value
Published on 03/19/2026 at 23:48, 4 hours 36 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/19/2026 at 22:55, 5 hours 29 minutes ago

Baristas behind millions of cups of coffee compete globally
Published on 03/19/2026 at 22:48, 5 hours 36 minutes ago

EQS-Adhoc: Forecast for the 2026 financial year
Published on 03/19/2026 at 19:30, 8 hours 54 minutes ago

EEII AG: Publication of Listing Prospectus

Les Echos

Published on 03/19/2026 at 18:00, 10 hours 24 minutes ago

Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 15:00, 13 hours 24 minutes ago

Statement Accor
Published on 03/19/2026 at 08:45, 19 hours 39 minutes ago

Deezer and Sonos renew and expand long-term collaboration
Published on 03/19/2026 at 07:00, 21 hours 24 minutes ago

bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE® SPOTFIRE® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe
Published on 03/19/2026 at 07:00, 21 hours 24 minutes ago

2025 Annual results and new strategic signature

View all LES ECHOS COMFI WIRE